Vaccines

Offers prophylactic products, and researches novel treatments for bacterial and viral infections. Includes projects, pipeline, news, global links and contacts for manufacturer in Marburg, Germany.

Development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease, with research and product details. Brisbane, California.

Develops, manufactures and supplies vaccines for prophylaxis and therapy. Includes resource page for bacterial and viral diseases, corresponding products, company biography, links to contacts and sites worldwide.

Develops, manufactures and markets formulations for use in immunization programs, including live virus vaccines. Includes patients guide to products, UK and US contacts, with investor relations and corporate communications in Gaithersburg, Maryland. (Nasdaq: AVIR)

Developer of vaccines for the prevention and treatment of infectious diseases.

Developer of vaccines against infectious disease, featuring smallpox-related products, investor information, company news, and career opportunities in both Cambridge, England and Massachusetts. ( Nasdaq: ACAM ) ( LSE: ACM )

Developer and manufacturer offering prevention and treatment of infectious diseases, with pre-clinical research programs, and has established products for HIV and smallpox. Overview includes investor data from Kvistgaard, Denmark.

VIDO conducts research in immunization technology, offering partnership with manufacturers for livestock and humans. Includes project overview, patents and contract services available from University of Saskatchewan, Saskatoon, Canada.

Developing a portfolio of immunotherapeutics for infectious diseases and cancer using its proprietary boosting regime. Includes overview of technology, publications and corporate profile, with contacts in Oxford, England and Boston, Massachusetts.

Developing gene-based treatments for cancer and infectious disease vaccines. Uses DNA technology and proprietary lipids to deliver genes. Includes clinical trial information and contacts in San Diego, California. (Nasdaq: VICL)

Tharapies against hepatitis C, EGFR, the Gag protein of the HIV virus and oncogene-related mutations in human cancer. Includes technology overview, progress of clinical trials, and profile of company in Aurora Colorado.

Develops products used to treat acute sickle cell crisis, vascular diseases, and technologies to improve effectiveness of vaccines, gene and drug delivery, and growth supplements. Based in Los Angeles, California. (Nasdaq: CYTR)

Develops new classes of diagnostic and therapeutic products for the detection, monitoring, and treatment of immune disorders and autoimmune diseases. based in Needham, Massachusetts. (Nasdaq: AVAN)

Manufactures pediatric, adult and clinical vaccines for diseases including hepatitis A and B, diphtheria and tetanus. Includes product list, disease prevention guide and patient information. Manufactured in Belgium and distributed from North Carolina.

Resource for articles, frequently asked questions, tools, literature, resources, and online services. Maintained by Aldevron LLC, Fargo, North Dakota.

Develops, manufactures, and markets proprietary products for treatment of human immunodeficiency virus infection and autoimmune diseases. Technical details for investors, and contacts for headquarters in Carlsbad, California. (Nasdaq: IMNR).

Creates and develops medical therapies, based on stress protein-based immunotherapeutics. Includes technology, clinical trials and corporate overview, with contacts in Victoria, British Columbia and San Diego, California.

Developing therapeutic vaccines against carcinoma, melanoma, leukemia and HIV. Includes pipeline for monoclonal for lupus, RNA-loaded dendritic cell technology and profile of company in Durham, North Carolina.

Company focusing on the development and commercialization of agents to prevent and control antibiotic resistant infections and inflammatory diseases. Includes explanation of modalities, services offered for microbial and tumor testing, details for investors and careers in Montreal, Canada.

Manufacturers triple antigen for diphtheria, tetanus and pertussis, and formulations for measles, mumps, rubella and hepatitis B. Includes overview of research, quality assurance, other products, and branches throughout the country.

Develops proteosomes as delivery vehicles, with a gene-based testing platform for the identification of disease-causing bacteria from culture and other growth methods. Contacts in North America, with head office in Vancouver, British Columbia. (Nasdaq: IDBE)